Literature DB >> 6818896

Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes.

J Engel, D E Kuhl, M E Phelps, J C Mazziotta.   

Abstract

Interictal positron computed tomography (PCT) with 18F-fluorodeoxyglucose was performed on 50 patients with partial seizures disorders. Electroencephalographic (EEG) monitoring was carried out during the metabolic studies using scalp and sphenoidal electrodes in 33 patients and stereotaxically implanted depth electrodes in 17. Four patients in this series had focal abnormalities on x-ray computed tomographic scans, but these were at the site of the presumed epileptogenic lesion in only 2. One or more discrete zones of hypometabolism were identified in 35 patients, and only 1 patient appeared to show focal interictal hypermetabolism. No quantitative relationship could be demonstrated between the degree of focal hypometabolism and either the frequency of interictal EEG spikes of the presence of focal nonepileptiform EEG changes. It was concluded that metabolic and electrophysiological techniques measure different aspects of cerebral dysfunction in seizure disorders. Although interictal PCT in patients with partial epilepsy usually demonstrates zones of hypometabolism this finding, per se, does not reveal the epileptic nature of the abnormality.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818896     DOI: 10.1002/ana.410120603

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  29 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

3.  Cerebral perfusion alterations during the acute phase of experimental generalized status epilepticus: prediction of survival by using perfusion-weighted MR imaging and histopathology.

Authors:  T Engelhorn; A Doerfler; J Weise; M Baehr; M Forsting; A Hufnagel
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

Review 4.  PET: its clinical role in neurology.

Authors:  D Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

5.  Single photon emission computed tomography with 99mTc HM-PAO in the study of focal epilepsy.

Authors:  E Grasso; L Ambrogio; A Cognazzo; P C Gerbino-Promis; P Zagnoni; G F Camuzzini; A Papaleo; F Acchiardi; G Perno
Journal:  Ital J Neurol Sci       Date:  1989-04

Review 6.  PET scanning.

Authors:  R S Frackowiak; T Jones
Journal:  BMJ       Date:  1989-03-18

7.  Interictal regional slow activity in temporal lobe epilepsy correlates with lateral temporal hypometabolism as imaged with 18FDG PET: neurophysiological and metabolic implications.

Authors:  M Koutroumanidis; C D Binnie; R D Elwes; C E Polkey; P Seed; G Alarcon; T Cox; S Barrington; P Marsden; M N Maisey; C P Panayiotopoulos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

8.  Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice.

Authors:  Olav B Smeland; Mussie G Hadera; Tanya S McDonald; Ursula Sonnewald; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

9.  Dynamic seizure-related changes in extracellular signal-regulated kinase activation in a mouse model of temporal lobe epilepsy.

Authors:  C R Houser; C S Huang; Z Peng
Journal:  Neuroscience       Date:  2008-07-10       Impact factor: 3.590

10.  Correlations between cerebral blood flow variations and clinical parameters in temporal lobe epilepsy: an interictal study.

Authors:  J Valmier; J Touchon; P Daures; M Zanca; M Baldy-Moulinier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.